Youn, Trisha Y MD

Dr Saliby started her medical studies at The Lebanese University then The American University of Beirut. She then pursued a fellowship in Endocrinology and Metabolism at Baylor College of Medicine where she focused her research on familial thyroid cancer at MD Anderson Cancer Center. She also trained in Internal Medicine at UT-Houston Medical Center and at Weill Cornell-New York Presbyterian Internal Medicine programs, following which she became certified by The American Board of Internal Medicine and a Diplomate in Endocrinology, Diabetes and metabolism.She joined Beth Israel Medical Center and the Albert Einstein Faculty in 2003 where she practiced and actively participated in the teaching of residents and fellows until 2016. During her career at Beth Israel, she conducted several clinical trials in diabetes and heart disease and diabetes and obesity. She also had a busy clinic for thyroid cancer at New York Eye and Ear, treating for 11 years over 400 patients. Dr Saliby joined the Weill Cornell faculty and New York Presbyterian Hospitals in July 2016. She serves as the Director of the Endocrinology Services at the Lower Manhattan Campus and sees patients in both the Lower Manhattan and the Upper East Side offices.Her interests remain in thyroid disease and thyroid cancer in particular, as well as in Diabetes and Metabolic diseases.

Bradley B. Pua, M.D.Chief, Division of Interventional Radiology Director, Lung Cancer Screening Program Director, Radiology Consultation ServicesDr. Bradley Pua is a nationally recognized leader in Interventional Radiology, known for advancing multidisciplinary care, early cancer detection, and procedural innovation. He earned his B.S. in Chemistry from New York University (NYU) and completed his M.D. at NYU School of Medicine. After three years of surgical residency at NYU Medical Center, he trained in Interventional Radiology through a fellowship at NewYork-Presbyterian/Weill Cornell and Memorial Sloan Kettering Cancer Center. He completed his diagnostic radiology residency at Cornell, serving as Chief Resident.Dr. Pua’s clinical practice includes a wide range of image-guided therapies such as embolization, stent placement, tumor ablation, biopsy, and vascular access. His focus areas include pediatric interventions and minimally invasive cancer therapy, with particular expertise in thoracic tumors.He co-founded a multidisciplinary vascular anomalies team that provides coordinated, longitudinal care for patients with hemangiomas, arteriovenous malformations, venous anomalies, and lymphatic disorders.As Director of the Lung Cancer Screening Program, Dr. Pua has streamlined diagnostic and therapeutic pathways for pulmonary nodules, accelerating access to curative treatment. He leads and collaborates on multiple clinical trials focused on minimally invasive lung tumor treatment, utilizing advanced techniques such as radiofrequency, microwave, cryoablation, and pulsed electric field ablation.A champion of emerging technology, Dr. Pua integrates augmented reality (AR) solutions into procedural planning and image-guided interventions. His work explores how AR overlays can enhance precision, safety, and outcomes across interventional oncology and complex vascular treatments.https://www.cbsnews.com/newyork/news/how-2-new-yorkers-are-tipping-the-odds-of-lung-cancer-survival/

For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 800-525-2225, Monday through Friday between 8:30 AM and 5:30 PM ET.